Edap TMS SA (EDAP)Healthcare | Medical Distribution | Vaulx-en-Velin, France |
USD
|
Hot Take ↕ | Aug. 22, 2026, 6 a.m. UTC
The company is undergoing a painful transformation, having recently rebranded to FocalTherics to pivot exclusively toward high-growth robotic focal therapy. However, the financial reality remains stark: the business is currently hemorrhaging cash with negative operating and free cash flows, while posting significant losses that result in negative earnings per share. This fundamental deterioration is reflected in the market's assessment, as the stock has suffered a severe multi-year decline, trading well below its historical lows despite a recent analyst initiation suggesting an outperform rating on future HIFU prospects. With no dividend to provide income and a balance sheet showing debt levels significantly exceeding equity, the investment case relies entirely on a successful turnaround that has not yet materialized in the numbers. The recent price action shows a slight uptick, but without the underlying profitability to support it, this appears more like speculative hope than a sustainable recovery. |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 275.141 |
| Revenue per Share | 1.977 |
| Market Cap | 161,922,176 |
| Forward P/E | -7.32 |
| Beta | -0.10 |
| Profit Margins | -41.70% |
| Website | https://focalone.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 1.55 |
| Address1 | Parc d’Activites la Poudrette-Lamartine |
| Address2 | 4/6, rue du Dauphiné |
| All Time High | 21.64 |
| All Time Low | 0.5 |
| Ask | 4.43 |
| Ask Size | 100 |
| Average Daily Volume10 Day | 43,695 |
| Average Volume | 37,020 |
| Average Volume10Days | 43,695 |
| Beta | -0.096 |
| Bid | 3.3 |
| Bid Size | 100 |
| Book Value | 0.518 |
| City | Vaulx-en-Velin |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | France |
| Currency | USD |
| Current Price | 4.32 |
| Current Ratio | 1.343 |
| Date Short Interest | 1,778,803,200 |
| Day High | 4.32 |
| Day Low | 4.32 |
| Debt To Equity | 275.141 |
| Ebitda | -22,187,500 |
| Ebitda Margins | -0.29954 |
| Enterprise To Ebitda | -8.651 |
| Enterprise To Revenue | 2.591 |
| Enterprise Value | 191,943,888 |
| Exchange | NGM |
| Exchange Timezone Name | UTC |
| Fifty Day Average | 3.8199 |
| Fifty Two Week High | 5.05 |
| Fifty Two Week Low | 1.21 |
| Financial Currency | USD |
| First Trade Date Epoch Utc | 1,784,295,000 |
| Float Shares | 28,056,016 |
| Forward Eps | -0.59 |
| Forward P E | -7.3220344 |
| Free Cashflow | -9,730,183 |
| Full Time Employees | 289 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.43409002 |
| Gross Profits | 32,154,000 |
| Held Percent Insiders | 0.06126 |
| Held Percent Institutions | 0.38869998 |
| Implied Shares Outstanding | 37,481,986 |
| Industry | Medical Distribution |
| Industry Disp | Medical Distribution |
| Industry Key | medical-distribution |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. This segment also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL segment manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithotripters. This segment also sells spare parts and disposables, such as electrodes. The Distribution segment markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales channels, and third-party distributors and agents. The company serves academic, public, and private hospitals, as well as clinics. The company has a strategic collaboration with Telix Pharmaceuticals Limited to develop clinical workflows combining PSMA PET imaging and Focal One Robotic HIFU for prostate cancer. EDAP TMS S.A. was incorporated in 1979 and is headquartered in Vaulx-en-Velin, France. |
| Long Name | Edap TMS SA |
| Market Cap | 161,922,176 |
| Max Age | 86,400 |
| Message Board Id | finmb_27892 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -30,885,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 233,137,952 |
| Number Of Analyst Opinions | 3 |
| Open | 4.46 |
| Operating Cashflow | -14,039,000 |
| Operating Margins | -0.41354 |
| Payout Ratio | 0.0 |
| Phone | 33 4 72 15 31 50 |
| Previous Close | 4.32 |
| Price Hint | 4 |
| Price To Book | 8.339768 |
| Price To Sales Trailing12 Months | 2.1860106 |
| Profit Margins | -0.41696 |
| Quick Ratio | 0.942 |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Regular Market Day High | 4.32 |
| Regular Market Day Low | 4.32 |
| Regular Market Open | 4.46 |
| Regular Market Previous Close | 4.32 |
| Regular Market Volume | 56,370 |
| Return On Assets | -0.20308 |
| Return On Equity | -1.23958 |
| Revenue Growth | 0.139 |
| Revenue Per Share | 1.977 |
| Sand P52 Week Change | 0.20282328 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 37,481,986 |
| Shares Percent Shares Out | 0.0015 |
| Shares Short | 57,027 |
| Shares Short Previous Month Date | 1,776,211,200 |
| Shares Short Prior Month | 37,921 |
| Short Name | EDAP TMS S.A. |
| Short Percent Of Float | 0.002 |
| Short Ratio | 1.54 |
| Symbol | EDAP |
| Target High Price | 10.0 |
| Target Low Price | 3.0 |
| Target Mean Price | 5.83333 |
| Target Median Price | 4.5 |
| Time Zone Full Name | America/New_York |
| Time Zone Short Name | EDT |
| Total Cash | 15,012,000 |
| Total Cash Per Share | 0.401 |
| Total Debt | 27,792,000 |
| Total Revenue | 74,072,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.82 |
| Trailing Peg Ratio | None |
| Two Hundred Day Average | 3.297984 |
| Underlying Symbol | EDAP |
| Uuid | 351bae4d-139a-3784-a392-7919dd37a0d5 |
| Volume | 56,370 |
| Website | https://focalone.com |
| Zip | 69,120 |